140 related articles for article (PubMed ID: 9169821)
1. Dynamics of tumor oxygenation, CD31 staining and transforming growth factor-beta levels after treatment with radiation or cyclophosphamide in the rat 13762 mammary carcinoma.
Kakeji Y; Maehara Y; Ikebe M; Teicher BA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1115-23. PubMed ID: 9169821
[TBL] [Abstract][Full Text] [Related]
2. Reduced oxygenation in a rat mammary carcinoma after chemo- or radiation therapy and reoxygenation with perflubron emulsion/carbogen breathing.
Teicher BA; Sotomayor EA; Dupuis NP; Kusumoto T; Menon K
J Cancer Res Clin Oncol; 1994; 120(10):593-8. PubMed ID: 7929530
[TBL] [Abstract][Full Text] [Related]
3. PEG-hemoglobin: effects on tumor oxygenation and response to chemotherapy.
Teicher BA; Ara G; Herbst R; Takeuchi H; Keyes S; Northey D
In Vivo; 1997; 11(4):301-11. PubMed ID: 9292296
[TBL] [Abstract][Full Text] [Related]
4. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
Teicher BA; Holden SA; Ara G; Dupuis NP; Goff D
Cancer J Sci Am; 1995; 1(1):43-8. PubMed ID: 9166453
[TBL] [Abstract][Full Text] [Related]
5. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.
Teicher BA; Williams JI; Takeuchi H; Ara G; Herbst RS; Buxton D
Anticancer Res; 1998; 18(4A):2567-73. PubMed ID: 9703911
[TBL] [Abstract][Full Text] [Related]
6. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.
Lee CG; Heijn M; di Tomaso E; Griffon-Etienne G; Ancukiewicz M; Koike C; Park KR; Ferrara N; Jain RK; Suit HD; Boucher Y
Cancer Res; 2000 Oct; 60(19):5565-70. PubMed ID: 11034104
[TBL] [Abstract][Full Text] [Related]
7. Reversal of in vivo drug resistance by the transforming growth factor-beta inhibitor decorin.
Teicher BA; Maehara Y; Kakeji Y; Ara G; Keyes SR; Wong J; Herbst R
Int J Cancer; 1997 Mar; 71(1):49-58. PubMed ID: 9096665
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis.
Breier G; Blum S; Peli J; Groot M; Wild C; Risau W; Reichmann E
Int J Cancer; 2002 Jan; 97(2):142-8. PubMed ID: 11774256
[TBL] [Abstract][Full Text] [Related]
9. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
Dupuis NP; Kusumoto T; Robinson MF; Liu F; Menon K; Teicher BA
Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):423-9. PubMed ID: 7493063
[TBL] [Abstract][Full Text] [Related]
10. Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy.
Hansen-Algenstaedt N; Stoll BR; Padera TP; Dolmans DE; Hicklin DJ; Fukumura D; Jain RK
Cancer Res; 2000 Aug; 60(16):4556-60. PubMed ID: 10969807
[TBL] [Abstract][Full Text] [Related]
11. Preferential topography of proteins regulating vascularization and apoptosis in a MX1 xenotransplant after treatment with hypoxia, hyperthermia, ifosfamide, and irradiation.
Schmitt O; Schubert C; Feyerabend T; Hellwig-Bürgel T; Weiss C; Kühnel W
Am J Clin Oncol; 2002 Aug; 25(4):325-36. PubMed ID: 12151958
[TBL] [Abstract][Full Text] [Related]
12. Reduced oxygenation in a rat mammary carcinoma post-radiation and reoxygenation with a perflubron emulsion/carbogen breathing.
Teicher BA; Dupuis NP; Robinson MF; Kusumoto T; Liu M; Menon K
In Vivo; 1994; 8(1):125-31. PubMed ID: 8054502
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas.
Ding I; Sun JZ; Fenton B; Liu WM; Kimsely P; Okunieff P; Min W
Cancer Res; 2001 Jan; 61(2):526-31. PubMed ID: 11212245
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
Takahashi N; Haba A; Matsuno F; Seon BK
Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
[TBL] [Abstract][Full Text] [Related]
15. Estrogen regulates vascular endothelial growth/permeability factor expression in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
Nakamura J; Savinov A; Lu Q; Brodie A
Endocrinology; 1996 Dec; 137(12):5589-96. PubMed ID: 8940388
[TBL] [Abstract][Full Text] [Related]
16. Host distribution and response to antitumor alkylating agents of EMT-6 tumor cells from subcutaneous tumor implants.
Holden SA; Emi Y; Kakeji Y; Northey D; Teicher BA
Cancer Chemother Pharmacol; 1997; 40(1):87-93. PubMed ID: 9137536
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced hypoxia may perpetuate late normal tissue injury.
Vujaskovic Z; Anscher MS; Feng QF; Rabbani ZN; Amin K; Samulski TS; Dewhirst MW; Haroon ZA
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):851-5. PubMed ID: 11429211
[TBL] [Abstract][Full Text] [Related]
18. beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.
Teicher BA; Sotomayor EA; Huang ZD; Ara G; Holden S; Khandekar V; Chen YN
Cancer Chemother Pharmacol; 1993; 33(3):229-38. PubMed ID: 8269604
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta in in vivo resistance.
Teicher BA; Holden SA; Ara G; Chen G
Cancer Chemother Pharmacol; 1996; 37(6):601-9. PubMed ID: 8612316
[TBL] [Abstract][Full Text] [Related]
20. Antitumor efficacy and pharmacokinetic analysis of 4-hydroperoxycyclophosphamide in comparison with cyclophosphamide +/- hepatic enzyme effectors.
Teicher BA; Holden SA; Goff DA; Wright JE; Tretyakov O; Ayash LJ
Cancer Chemother Pharmacol; 1996; 38(6):553-60. PubMed ID: 8823498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
